In breast oncology there is a pre-TDXd & a post-TDXd era, with the latter still at the dawn – Paolo Tarantino

ESMO Members are invited to vote for the candidates running for the ESMO Nomination Committee Chair and four Member positions – ESMO

Meta-analysis on the prognostic value of HER2-low in breast cancer – Guilherme Nader Marta

Cancer patients’ access to advanced genetic testing is not keeping up with the pace of discovery of targetable mutations and personalised therapies – European Society for Medical Oncology

We are opening a new travel grant that’ll take you to #ESMO23 – ABC Global Alliance

Congratulations Christoph Zielinski for this important achievement and for ESMO – European Society for Medical Oncology initiative!  – Evandro de Azambuja

The formatted version of the ESMO Consensus Statements on HER2-low breast cancer is finally published – Paolo Tarantino

At ESMO Breast we witnessed the true power of co-creation and cross-functional collaboration – Nana Scotto

ESMO POWG Practising Oncologists working group meeting in Berlin